Bharat Coking Coal IPO: 50% GMP Looks Tempting—But It’s Pricing a “Perfect Debut” While Fundamentals Are Still Mixed

Bharat Coking Coal’s grey market premium (GMP) of ~₹11.5 implies ~50% upside to ~₹34–₹35 versus the ₹23 upper band, setting up a strong listing-pop narrative ahead of the Jan 9 opening. ​ But GMP is an unofficial sentiment marker, not a cash-flow proof—and the bigger call is whether investors are buying a scarce PSU coking-coal franchise or simply front-running a debut trade. What the issue structure signals The ₹1,071.11 crore IPO is a 100% offer-for-sale (OFS) of 46.57 crore shares by

, with no fresh capital raised for BCCL—so this is primarily a divestment/float-creation event, not a growth-funding event. ​ The issue runs Jan 9–13, with allotment expected around Jan 14 and listing targeted for Jan 16 on BSE and NSE. The operational strength that supports the buzz BCCL is described as India’s largest domestic coking coal producer, with coking coal reserves of ~7,910 million tonnes and ~58.5% share of domestic coking coal output in FY25. ​ Coal production has risen from 30.51 mt in FY22 to 40.50 mt in FY25, which gives investors a “volume growth” backbone to the listing optimism. The numbers investors must not ignore FY25 revenue was ₹14,402 crore (down ~1.7% YoY), while profit fell ~20% to ₹1,240 crore—so the near-term earnings trajectory is not cleanly upward even before listing exuberance. ​ Broker notes in the same report highlight valuation anchors (e.g., EV/EBITDA multiples around mid-single digits depending on method) and also flag concentration/structural risks like reserve depletion, customer concentration (>80% revenue from top 10 customers), and renewables-driven demand risk over time. The real test after day one If the IPO lists at a big premium, the credibility test shifts to whether secondary buying shows up after the “GMP trade” exits—because that’s where long-only conviction and valuation comfort are revealed. Source: Economic Times No Recommendation